Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
Completed
The purpose of this study is to test the safety of Iodine-131 Anti-B1 Antibody followed by CHOP and to see what effects it has on patients with previously untreated mantel cell lymphoma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/23/2005
Locations: Rush-Presbyterian-St. Lukes Medical Center, Chicago, Illinois +2 locations
Conditions: Mantle Cell Lymphoma
Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia
Completed
OBJECTIVES: I. Determine the probability of engraftment with total body irradiation, cyclophosphamide, fludarabine, and anti-thymocyte globulin followed by HLA nongenotypically identical donor, T-cell depleted hematopoietic cell transplantation in patients with Fanconi's anemia. II. Determine the incidence of acute and chronic graft-versus-host disease in these patients after undergoing this treatment regimen. III. Determine the one-year survival rate in these patients after undergoing this tr... Read More
Gender:
ALL
Ages:
Between 0 years and 34 years
Trial Updated:
06/23/2005
Locations: University of Minnesota Cancer Center, Minneapolis, Minnesota
Conditions: Fanconi's Anemia